NDC 17856-0508-01 - NYSTATIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0508
- Requested NDC
- 17856-0508-01
- Package NDCs from labels
- 17856-0508-1, 17856-0508-3, 17856-0508-5, 17856-0508-7, 17856-0508-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NYSTATIN ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0508-1 | NYSTATIN | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 3 | |
| 17856-0508-1 | NYSTATIN | 72 in 1 BOX, UNIT-DOSE | SUSPENSION | 72 | 3 | |
| 17856-0508-3 | NYSTATIN | 5 mL in 1 SYRINGE | SUSPENSION | 5 | 3 | |
| 17856-0508-3 | NYSTATIN | 48 in 1 BOX, UNIT-DOSE | SUSPENSION | 48 | 3 | |
| 17856-0508-5 | NYSTATIN | 48 in 1 BOX, UNIT-DOSE | SUSPENSION | 48 | 3 | |
| 17856-0508-5 | NYSTATIN | 5 mL in 1 SYRINGE | SUSPENSION | 5 | 3 | |
| 17856-0508-7 | NYSTATIN | 1 mL in 1 SYRINGE | SUSPENSION | 1 | 3 | |
| 17856-0508-7 | NYSTATIN | 120 in 1 BOX, UNIT-DOSE | SUSPENSION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0508 | NYSTATIN SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, 8 package rows | 20240719_5c08148f-83e5-4f14-b0d3-af8d2c26062e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0508-7 | ML - Milliliter | 17856-0508 | 088e446d-e273-4df0-9669-405c41d60af5 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Teva Pharmaceuticals USA, Inc. | f03b294d-10cd-4bba-92c8-42ae9b110cd0 | 2022-11-01 | Adverse reactions | BDF1O1C72E |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Viona Pharmaceuticals Inc | d3799da3-5923-4225-9c61-2b5af143f555 | 2022-10-08 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Viona Pharmaceuticals Inc | e135a7d2-adba-48a2-b3e1-07b778cce9b0 | 2022-10-08 | Adverse reactions | BDF1O1C72E |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Nystatin | NYSTATIN | Proficient Rx LP | d7d04c02-d07d-4382-8f93-5c0c3e68790c | 2022-10-01 | Adverse reactions | BDF1O1C72E |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX K679OBS311 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | PDC6A3C0OX K679OBS311 |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX K679OBS311 |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX K679OBS311 |
| REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 | 2022-06-28 | Warnings | K679OBS311 |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Ethylicum (ETOH, aka Alcoholus) | ETHYLICUM (ETOH, AKA ALCOHOLUS) | Hahnemann Laboratories, INC. | e1fef03a-ed76-4294-e053-2995a90aee67 | 2022-06-21 | 3K9958V90M | |
| REFRESH TEARS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 329d1fe0-4432-4565-b7b1-65666bd86526 | 2022-06-16 | Warnings | K679OBS311 |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Nystatin | NYSTATIN | Proficient Rx LP | e7f0e152-233a-492e-a297-7bf2c543c113 | 2022-05-02 | Adverse reactions | BDF1O1C72E |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Fresenius Kabi USA, LLC | 5bf47be3-f3fe-452b-8113-941796498345 | 2022-03-31 | Warnings, Adverse reactions | 22ADO53M6F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.